Form 4: Serina Therapeutics Director Gregory Bailey Reports Stock Purchase
SEC Form 4
Director Gregory Bailey of Serina Therapeutics, Inc. reports purchasing 1,422 shares of common stock at $9.50 per share on May 21, 2024.
Summary
- On May 21, 2024, Gregory Bailey, a director of Serina Therapeutics, Inc. (SER), purchased 1,422 shares of common stock.
- The purchase price was $9.50 per share.
- Following the transaction, Bailey directly owns 1,522 shares of Serina Therapeutics.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It reflects a routine transaction by a company director. The purchase could be interpreted as a positive signal, but without further context, it's difficult to gauge the overall impact.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The stock purchase by a director could positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/21/2024 | Date of stock purchase transaction |
| 05/23/2024 | Date of signature on the Form 4 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.